Analysts predict that Monsanto Company (NYSE:MON) will post sales of $2.46 billion for the current quarter, according to Zacks. Two analysts have issued estimates for Monsanto’s earnings, with estimates ranging from $2.38 billion to $2.54 billion. Monsanto reported sales of $2.56 billion during the same quarter last year, which would suggest a negative year-over-year growth rate of 3.9%. The company is expected to announce its next earnings results before the market opens on Wednesday, October 4th.
According to Zacks, analysts expect that Monsanto will report full-year sales of $2.46 billion for the current year, with estimates ranging from $13.64 billion to $14.59 billion. For the next fiscal year, analysts anticipate that the company will report sales of $14.70 billion per share, with estimates ranging from $14.34 billion to $15.11 billion. Zacks’ sales calculations are an average based on a survey of analysts that follow Monsanto.
Monsanto (NYSE:MON) last posted its quarterly earnings results on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.74 by $0.19. The business had revenue of $4.23 billion for the quarter, compared to analyst estimates of $4.18 billion. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. The business’s revenue was up 1.0% compared to the same quarter last year. During the same period in the prior year, the company posted $2.17 EPS.
A number of analysts have commented on MON shares. Zacks Investment Research downgraded Monsanto from a “buy” rating to a “hold” rating in a research report on Tuesday, September 5th. BMO Capital Markets restated a “buy” rating and set a $128.00 target price on shares of Monsanto in a research report on Friday, September 1st. BidaskClub upgraded Monsanto from a “sell” rating to a “hold” rating in a research report on Saturday, August 19th. Royal Bank Of Canada restated a “sector perform” rating and set a $128.00 target price (up previously from $120.00) on shares of Monsanto in a research report on Thursday, June 29th. Finally, Vetr upgraded Monsanto from a “hold” rating to a “buy” rating and set a $122.35 target price for the company in a research report on Wednesday, July 12th. One investment analyst has rated the stock with a sell rating, eleven have given a hold rating and eight have issued a buy rating to the company’s stock. Monsanto currently has a consensus rating of “Hold” and a consensus price target of $123.43.
In related news, EVP Steven Mizell sold 11,300 shares of Monsanto stock in a transaction on Monday, July 3rd. The stock was sold at an average price of $118.57, for a total transaction of $1,339,841.00. Following the completion of the sale, the executive vice president now directly owns 55,011 shares of the company’s stock, valued at $6,522,654.27. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, EVP Robert T. Fraley sold 52,410 shares of Monsanto stock in a transaction on Monday, July 10th. The stock was sold at an average price of $117.95, for a total value of $6,181,759.50. The disclosure for this sale can be found here. 0.79% of the stock is owned by insiders.
Several institutional investors have recently made changes to their positions in MON. Acrospire Investment Management LLC acquired a new stake in shares of Monsanto during the first quarter worth $113,000. Pinnacle Financial Partners Inc. acquired a new stake in shares of Monsanto during the second quarter worth $114,000. Bruderman Asset Management LLC acquired a new stake in shares of Monsanto during the second quarter worth $116,000. Tower Research Capital LLC TRC grew its stake in shares of Monsanto by 230.1% during the second quarter. Tower Research Capital LLC TRC now owns 1,076 shares of the basic materials company’s stock worth $128,000 after purchasing an additional 750 shares during the period. Finally, JNBA Financial Advisors grew its stake in shares of Monsanto by 3.9% during the first quarter. JNBA Financial Advisors now owns 1,193 shares of the basic materials company’s stock worth $135,000 after purchasing an additional 45 shares during the period. 74.79% of the stock is owned by institutional investors and hedge funds.
Monsanto (NYSE MON) opened at 117.44 on Wednesday. The company’s 50-day moving average price is $117.21 and its 200-day moving average price is $116.36. Monsanto has a 52 week low of $97.35 and a 52 week high of $118.97. The company has a market capitalization of $51.59 billion, a P/E ratio of 25.37 and a beta of 1.07.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, October 6th will be paid a dividend of $0.54 per share. The ex-dividend date is Thursday, October 5th. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.84%. Monsanto’s dividend payout ratio (DPR) is presently 46.75%.
TRADEMARK VIOLATION WARNING: “Analysts Expect Monsanto Company (MON) Will Post Quarterly Sales of $2.46 Billion” was first published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece on another site, it was illegally copied and reposted in violation of United States and international trademark and copyright legislation. The original version of this piece can be viewed at https://www.tickerreport.com/banking-finance/2888355/analysts-expect-monsanto-company-mon-will-post-quarterly-sales-of-2-46-billion.html.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.